• 1 Department of Cardiovascular Medicine, Ikuwakai Memorial Hospital, 3-20-29 Tatsumikita, Ikunoku, Osaka, Osaka, 544-0004, Japan.
  • 2 Department of Cardiology, New Tokyo Hospital, Matsudo, Japan
  • 3 Department of Cardiovascular Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan
  • 4 Division of Cardiology, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei, Taiwan
  • 5 Department of Cardiology, Busan Veterans Hospital, Busan, Korea
  • 6 Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea
  • 7 Department of Vascular Surgery, Daegu Catholic University Hospital, Daegu, Korea
  • 8 Department of Vascular Laboratory, Ikuwakai Memorial Hospital, Osaka, Japan
  • 9 Department of Cardiology, Rakuwakai Otowa Hospital, Kyoto, Japan
  • 10 Department of Cardiology, Kyoto Second Red Cross Hospital, Kyoto, Japan
  • 11 Department of Radiology, Nara Medical University, Kashihara, Japan
  • 12 Division of Vascular Surgery, Tokyo Saiseikai Central Hospital, Tokyo, Japan
  • 13 Department of Cardiology, Kishiwada Tokushukai Hospital, Kishiwada, Japan
  • 14 Department of Radiology, Tsuchiya General Hospital, Hiroshima, Japan
  • 15 Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Sha Tin, Hong Kong, China
  • 16 Department of Surgery, Pamela Youde Nethersole Eastern Hospital, Chai Wan, Hong Kong, China
  • 17 Department of Vascular Surgery, Siriraj Hospital, ‎Bangkok, Thailand
  • 18 Department of Vascular Surgery, Cardiac Vascular Sentral Kuala Lumpur, Kuala Lumpur, Malaysia
  • 19 Department of Vascular Surgery, Vascular and Interventional Centre Singapore, Mount Elizabeth Novena Specialist Centre, The Farrer Park Hospital, Singapore, Singapore
  • 20 Department of Vascular Surgery, Narayana Hrudayalaya and Mazumdar Shaw Medical Centre, Bengaluru, India
  • 21 Division of Cardiology, Department of Internal Medicine, Tainan Municipal Hospital, Tainan, Taiwan
  • 22 Department of Cardiology, National Taiwan University, Taipei, Taiwan
  • 23 Department of Cardiology, China Medical University Hospital, Taichung, Taiwan
  • 24 Department of Radiology, Tan Tock Seng Hospital, Singapore, Singapore
  • 25 Department of Cardiology, Funabashi Municipal Medical Center, Funabashi, Japan
  • 26 Department of Cardiology, Hyogo College of Medicine, Nishinomiya, Japan
  • 27 Department of Cardiology, Yokohama City University Medical Center, Yokohama, Japan
  • 28 Department of Surgery, Keio University School of Medicine, Tokyo, Japan
Cardiovasc Interv Ther, 2020 Jan;35(1):52-61.
PMID: 31292931 DOI: 10.1007/s12928-019-00602-z


With technological improvements in the endovascular armamentarium, there have been tremendous advances in catheter-based femoropopliteal artery intervention during the last decade. However, standardization of the methodology for assessing outcomes has been underappreciated, and unvalidated peak systolic velocity ratios (PSVRs) of 2.0, 2.4, and 2.5 on duplex ultrasonography have been arbitrarily but routinely used for assessing restenosis. Quantitative vessel analysis (QVA) is a widely accepted method to identify restenosis in a broad spectrum of cardiovascular interventions, and PSVR needs to be validated by QVA. This multidisciplinary review is intended to disseminate the importance of QVA and a validated PSVR based on QVA for binary restenosis in contemporary femoropopliteal intervention.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.